NVMI NOVA LTD. Annual reports only
Optical Instruments & Lenses · Nasdaq · SEC CIK 1109345 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY31.0%
TTM net income YoY41.1%
TTM EPS YoY38.4%
Revenue 3-yr CAGR15.6%
Net income 3-yr CAGR22.7%
Margins
Gross margin57.4%
Operating margin28.8%
Net margin29.4%
FCF margin24.7%
EBITDA margin30.3%
Returns
ROE23.1%
ROA13.8%
ROIC (approx.)23.1%
Asset turnover0.47x
Leverage & solvency
Liabilities / assets44.2%
Debt / equity0.00x
Current ratio6.28x
Interest coverage126.99x
Cash quality & payout
Operating cash flow / net income0.95x
Accruals ratio0.7%
Payout ratio—
Capex / revenue3.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $880.58M | $672.40M |
| Cost of revenue | $375.38M | $285.31M |
| Gross profit | $505.20M | $387.09M |
| R&D expense | $143.39M | $110.26M |
| SG&A expense | $26.13M | $24.20M |
| Operating income | $253.47M | $187.54M |
| Interest expense | $2.00M | $1.28M |
| Pretax income | $303.29M | $216.29M |
| Income tax | $44.06M | $32.52M |
| Net income | $259.22M | $183.76M |
| EBITDA | $266.94M | $199.28M |
| EPS (basic) | 8.61 | 6.31 |
| EPS (diluted) | 7.96 | 5.75 |
| Weighted avg. shares (diluted) | 32,800 | 32,138 |
| Banking | ||
| Net interest income | $45.67M | $34.55M |
| Balance sheet | ||
| Cash & equivalents | $214.46M | $157.78M |
| Short-term investments | $321.80M | $216.91M |
| Receivables | $151.93M | $139.32M |
| Inventory | $183.67M | $156.60M |
| Current assets | $1.41B | $901.95M |
| PP&E, net | $102.62M | $81.75M |
| Goodwill | $90.81M | $48.32M |
| Intangibles | $45.82M | $31.46M |
| Total assets | $2.36B | $1.39B |
| Current liabilities | $224.53M | $388.23M |
| Total liabilities | $1.04B | $462.63M |
| Shareholders' equity | $1.32B | $927.79M |
| Shares outstanding | 31.78M | 29.28M |
| Cash flow statement | ||
| Operating cash flow | $245.61M | $235.27M |
| Capital expenditure | $27.70M | $17.21M |
| Free cash flow | $217.91M | $218.05M |
| Investing cash flow | -$837.17M | -$136.40M |
| Financing cash flow | $642.21M | -$48.35M |
| Depreciation & amortization | $13.47M | $11.74M |
| Stock-based compensation | $26.29M | $25.21M |
| Share buybacks | $35.00M | $30.00M |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.